C. difficile

Seres, indebted and in need of cash, agrees to sell microbiome pill to Nestle
BioPharma Dive
Thu, 06/6/24 - 11:46 am
Seres Therapeutics
microbiome
Nestle
C. difficile
Vedanta Biosciences doses first subject in Phase III C difficile prevention trial
Clinical Trials Arena
Wed, 05/22/24 - 11:24 am
Vedanta Biosciences
clinical trials
VE303
C. difficile
Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health
Pharma Voice
Thu, 02/22/24 - 11:45 am
Ferring Pharmaceuticals
gene therapy
microbiome
bladder cancer
C. difficile
FDA approves first oral microbiome therapy Vowst
Fierce Pharma
Thu, 04/27/23 - 11:53 am
Seres Therapeutics
microbiome
Vowst
SER-109
C. difficile
FDA
Vedanta Raises $106.5M to Advance New Class of C.diff Therapeutics
BioSpace
Tue, 04/25/23 - 10:00 pm
Vedanta Biosciences
funding
C. difficile
VE303
5 FDA decisions to watch in the second quarter
BioPharma Dive
Mon, 04/3/23 - 11:06 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Biogen
tofersen
ALS
Seres Therapeutics
C. difficile
Pfizer
GSK
vaccines
RSV
Regeneron
Eylea
FDA approves first fecal microbiome drug, setting stage for others
Stat
Thu, 12/1/22 - 10:41 am
Ferring Pharmaceuticals
Rebyota
FDA
C. difficile
fecal microbiome
microbiome
Seres one step closer to bringing first oral microbiome therapy to market as FDA mulls approval
Fierce Biotech
Wed, 10/26/22 - 10:51 am
Seres Therapeutics
microbiome
C. difficile
SER-109
FDA panel recommends Ferring's fecal transplant therapy
NASDAQ
Fri, 09/23/22 - 10:47 am
Ferring Pharmaceuticals
fecal transplants
C. difficile
FDA
One week after Takeda walked away, Finch faces second round of layoffs, pipeline pruning
Endpoints
Thu, 09/1/22 - 10:45 am
Finch Therapeutics
Takeda
layoffs
C. difficile
FDA's vaccine adcomm to review first fecal transplant to treat C. difficile infections
Endpoints
Mon, 08/8/22 - 11:39 pm
FDA
Ferring Pharmaceuticals
Rebiotix
RBX2660
C. difficile
Summit will take scenic route up FDA mountain after regulator recommends more trials for C. diff therapy
Fierce Biotech
Thu, 07/14/22 - 07:51 pm
Summit Therapeutics
ridinilazole
C. difficile
Plotting a comeback after 2016 flop, Seres to raise $100M to prep C. difficile program for launch
Endpoints
Thu, 06/30/22 - 11:04 am
Seres Therapeutics
microbiome
C. difficile
funding
Seres, Vera Notch Weekend Wins in C.Diff, Lupus Trials
BioSpace
Mon, 05/23/22 - 10:22 am
Seres Therapeutics
clinical trials
SER-109
C. difficile
Vera Therapeutics
lupus
atacicept
FDA lifts hold on Finch’s microbiome crapsule, as company looks to right ship
Endpoints
Fri, 04/29/22 - 10:34 am
Finch Therapeutics
FDA
microbiome
crapsules
clinical trials
C. difficile
Finch clips wings of hepatitis B program, hitting pause on clinical plan to focus on C. diff and autism
Fierce Biotech
Fri, 04/1/22 - 10:38 am
Finch Therapeutics
hepatitis B
microbiome
clinical trials
autism
C. difficile
The year the regulators meet the microbiome
EP Vantage
Thu, 03/24/22 - 10:47 am
microbiome
Seres Therapeutics
Ferring Pharmaceuticals
FDA
C. difficile
Summit says path forward for failed C. difficile drug is likely through partnerships
Fierce Biotech
Sun, 03/20/22 - 10:52 pm
Summit Therapeutics
Vancomycin
clinical trials
C. difficile
FDA slaps hold on Finch's C. diff med to get info on COVID-19 screening for donor-derived therapy
Fierce Biotech
Thu, 03/3/22 - 10:21 am
Finch Therapeutics
C. difficile
clinical hold
FDA
clinical trials
microbiome
Pfizer seeks silver lining in failed C. diff vaccine trial
Pharmaforum
Wed, 03/2/22 - 10:07 am
Pfizer
vaccines
clinical trials
C. difficile

Pages